Er:YAG + SMA Safe, Effective for Facial Skin Rejuvenation

This article originally appeared here.
Share this content:
Er:YAG + SMA Safe, Effective for Facial Skin Rejuvenation
Er:YAG + SMA Safe, Effective for Facial Skin Rejuvenation

MONDAY, July 25, 2016 (HealthDay News) -- Multifractional microablative laser combined with spatially modulated ablative (SMA) technology appears to be effective and safe for facial skin rejuvenation, according to a study published online July 18 in Lasers in Surgery and Medicine.

Barbara Hersant, M.D., from Henri Mondor Hospital in Créteil France, and colleagues examined the clinical efficacy and safety of Erbium:YAG laser combined with SMA (Er:YAG + SMA) on facial skin rejuvenation. Thirty-four patients with Fitzpatrick skin types I to IV were included prospectively (50 percent had skin type III); patients had wrinkles and irregular skin texture. To stimulate tissue regeneration, all patients underwent two Er:YAG + SMA sessions one month apart.

The researchers observed a significant improvement in skin elasticity indices for R5 (net elasticity) (P = 0.05) from baseline to month six (M6). There was also a significant improvement in skin firmness, with an increase in biological elasticity (R7) and a decrease in viscoelastic ratio (R6) from baseline to M6. There was a correlation for a negative value for R6 with improvement in skin condition. From baseline there were significant increases in FACE-Q scores at M1 and M6, indicative of wrinkle reduction and enhanced rejuvenation. Results showed that patients felt younger at M1 and M6 according to the age appraisal visual analogue scale by −2.92 and −4.13 years, respectively (both P < 0.0001).

"The Er:YAG + SMA technology offers an effective and safe treatment alternative for facial skin rejuvenation," the authors write. "It reduces the recovery time compared to conventional lasers such as carbon dioxide laser."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »